Related Experiment Video
Updated: Jun 9, 2026
10:58
Production of E. coli-expressed Self-Assembling Protein Nanoparticles for Vaccines Requiring Trimeric Epitope Presentation
Published on: August 21, 2019
Nanoparticle vaccine formulations for dengue virus
Connor T Murphy1, Kristy M Ainslie1,2,3
1Division of Pharmacoengineering & Molecular Pharmaceutics, Eshelman School of Pharmacy, UNC 4012 Marsico Hall 125 Mason Farm Road Chapel Hill NC 27599 USA ainsliek@email.unc.edu.
RSC Pharmaceutics
|June 8, 2026
Summary
Nanoparticle vaccines offer a promising solution for Dengue virus (DENV) prevention, overcoming limitations of current vaccines. These advanced formulations minimize risks like antibody-dependent enhancement (ADE), improving Dengue protection.
Area of Science:
- Virology
- Immunology
- Nanotechnology
Background:
- Dengue virus (DENV) poses a significant global health threat, infecting nearly half the world's population.
- Current vaccines and antivirals for DENV are limited, creating a critical protection gap.
- Existing live-attenuated vaccines carry risks, including antibody-dependent enhancement (ADE), which can worsen DENV infection outcomes.
Purpose of the Study:
- To explore nanoparticle-based vaccine formulations as a novel strategy against Dengue virus.
- To evaluate the advantages of nanoparticle vaccines over traditional live-attenuated vaccines.
- To assess the potential of various nanoparticle carrier systems in inducing effective immune responses against DENV.
Main Methods:
- Review of existing literature on nanoparticle-based vaccine development for DENV.
- Analysis of different nanoparticle carrier systems (polymeric, lipid, inorganic, protein-based).
- Evaluation of immune responses, including humoral and cellular immunity, generated by these systems.
Main Results:
- Nanoparticle formulations offer advantages like controlled release, dose-sparing, and adjuvant/antigen encapsulation.
- These formulations can minimize the risk of antibody-dependent enhancement (ADE).
- Different nanoparticle systems elicit distinct antigen-specific immune activation profiles.
Conclusions:
- Nanoparticle-based vaccines represent a promising avenue for combating the growing threat of Dengue virus.
- Further research is needed to optimize these formulations for widespread use.
- Nanotechnology provides a versatile platform for developing safer and more effective Dengue vaccines.
